SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
EssilorLuxottica S.A. (ESLOY) trades at a trailing P/E of 50.5, forward P/E of 32.7. Trailing earnings yield is 1.98%, forward earnings yield 3.06%. PEG 0.60 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 50.5).
- Forward P/E 32.7 (down from trailing 50.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.60 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 1.98% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.06% as earnings recover.
Overall SharesGrow Score: 53/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ESLOY
Valuation Multiples
P/E (TTM)50.5
Forward P/E32.7
PEG Ratio0.60
Forward PEG0.60
P/B Ratio0.00
P/S Ratio4.10
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.39
Forward EPS (Est.)$3.70
Book Value / Share$0.00
Revenue / Share$29.45
FCF / Share$0.00
Yields & Fair Value
Earnings Yield1.98%
Forward Earnings Yield3.06%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.86 |
$7.12B |
$813M |
11.4% |
| 2017 |
$1.79 |
$9.18B |
$789M |
8.6% |
| 2018 |
$2.04 |
$10.83B |
$1.08B |
10% |
| 2019 |
$1.22 |
$17.39B |
$1.08B |
6.2% |
| 2020 |
$0.10 |
$14.43B |
$85M |
0.6% |
| 2021 |
$1.63 |
$19.82B |
$1.45B |
7.3% |
| 2022 |
$2.42 |
$24.49B |
$2.15B |
8.8% |
| 2023 |
$2.54 |
$25.4B |
$2.29B |
9% |
| 2024 |
$2.57 |
$26.51B |
$2.36B |
8.9% |
| 2025 |
$2.39 |
$27.37B |
$2.22B |
8.1% |
